ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716857; 2) Community: the network communities that were significantly associated with the response to NSC 716857; 3) Molecule: the relationships between components within communities and NSC 716857; 4) MDR: the compounds that were significantly associated with the NSC 716857.

NSC Compound Enrichment Correlation
NSC 623989 Null 0.0102077332082017 0.55381367
NSC 633398 Null 0.0102077332082017 0.33958399
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0102077332082017 0.47385229
NSC 644916 ANTINEOPLASTIC-644916 0.0102077332082017 0.5172377
NSC 646498 Null 0.0102077332082017 0.50852095
NSC 659853 2-Methoxy-.beta.-estradiol 0.0102077332082017 0.54493431
NSC 672472 Null 0.0102077332082017 0.44572539
NSC 673421 Null 0.0102077332082017 0.36534744
NSC 680715 Benzaldehyde, 5-bromo-2-hydroxy- (9CI) 0.0102077332082017 0.49740105
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0102077332082017 0.47094845
Total:131  Current:38    [First] [Prev] [Next] [Last]